Drug
Tmc-647055 clinical trials
Also written TMC647055.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2010
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
5 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Merck Sharp & Dohme LLC (2) · Janssen R&D Ireland (2) · Tibotec Pharmaceuticals, Ireland (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses tmc-647055 is read from its arms, and is right about nine times in ten.
Testing it · 5
- Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and Ritonavir When Administered in Combination in Healthy Participants (MK-1894-007)CompletedPhase 1Merck Sharp & Dohme LLCNCT01907724Written as TMC647055
- Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005)CompletedPhase 2Merck Sharp & Dohme LLCNCT01852604Written as TMC647055
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TMC647055 in Combination With Ritonavir (Part 1) and the Co-administration of TMC435, TMC647055 and Ritonavir (Part 2) in Healthy Japanese ParticipantsCompletedPhase 1Janssen R&D IrelandNCT02064842Written as TMC647055
- Study to Examine Multiple Doses of TMC647055 in Combination With TelaprevirCompletedPhase 1Janssen R&D IrelandNCT01582035Written as TMC647055
- TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected PatientsCompletedPhase 1Tibotec Pharmaceuticals, IrelandNCT01202825Written as TMC647055
Given in every arm · 1 — tmc-647055 is usual care beside what is tested
Codes
What other systems call tmc-647055 · ClinicalTrials.gg INT006155
- Wikidata Q27251314TMC-647055One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27251314 | TMC-647055 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.